New research shows that a treatment for retinal vein occlusion (RVO) yields long-lasting vision gains, with visual acuity remaining significantly above baseline at 5 years. However, many patients require ongoing treatment.

A scientific team supported by NIH has created a tiny, bioengineered 3-D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair of rare, devastating neuromuscular diseases.

A new analysis of national survey data reveals significant reductions in cigarette use among U.S. adults with major depression, substance use disorder or both from 2006 to 2019.

Women have a higher risk than men for developing Alzheimer’s disease and experience a broader range of cognitive symptoms—those related to thinking, learning and memory.

Minuscule involuntary eye movements, known as microsaccades, can occur even while staring at a fixed point in space.

A drug approved to treat high blood pressure, called verapamil, was found protective in people with type 1 diabetes.

Black children with asthma accessed community health centers less than White children, while Latino children (who prefer to speak either English or Spanish) were more likely to visit CHCs for acute, chronic and preventive care overall.

Law enforcement seizures of pills containing illicit fentanyl increased dramatically since 2018, according to a new NIDA-funded study published in Drug and Alcohol Dependence.

Schools with mandatory masking during the Delta surge had approximately 72 percent fewer cases of in-school transmission of SARS-CoV-2 compared with schools with optional or partial masking policies, according to an NIH-funded study

NIAID has launched a phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved Covid-19 vaccines.